Co-Authors
This is a "connection" page, showing publications co-authored by Atsushi Okumura and Patrick Hanley.
Connection Strength
0.559
-
Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models. Sci Transl Med. 2021 08 18; 13(607).
Score: 0.060
-
Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus. JCI Insight. 2021 05 24; 6(10).
Score: 0.059
-
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques. Cell Rep Med. 2021 04 20; 2(4):100230.
Score: 0.058
-
Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature. 2021 Feb; 590(7844):E24.
Score: 0.058
-
Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models. JCI Insight. 2020 12 03; 5(23).
Score: 0.057
-
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature. 2020 10; 586(7830):578-582.
Score: 0.056
-
A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques. Sci Adv. 2020 06; 6(24):eaba8399.
Score: 0.055
-
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature. 2020 09; 585(7824):273-276.
Score: 0.055
-
Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Nature. 2020 09; 585(7824):268-272.
Score: 0.055
-
Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets. Antiviral Res. 2017 07; 143:30-37.
Score: 0.044